Ibio Rg
Pre‑clinical biotech iBio develops AI‑driven antibody platforms (EngageTx, ShieldTx, StableHu) targeting cardiometabolic, obesity, and cancer diseases, with pipelines like IBIO‑101 and TROP‑2×CD3, supported by strategic collaborations.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 20
- HQ: San Diego
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.